Cargando…
Performance of international prognostic indices in plasmablastic lymphoma: a comparative evaluation
PURPOSE: Plasmablastic lymphoma (PBL) is a rare and aggressive B-cell malignancy with a heterogenous clinical and prognostic spectrum, determined by multiple factors, including age, HIV- and MYC-status. While there exist several validated scoring systems for diffuse large B-cell lymphoma, which inco...
Autores principales: | Hertel, Nadine, Merz, Hartmut, Bernd, Heinz-Wolfram, Bernard, Veronica, Künstner, Axel, Busch, Hauke, von Bubnoff, Nikolas, Feller, Alfred C., Witte, Hanno M., Gebauer, Niklas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8397630/ https://www.ncbi.nlm.nih.gov/pubmed/33660007 http://dx.doi.org/10.1007/s00432-021-03580-z |
Ejemplares similares
-
Integrative genomic and transcriptomic analysis in plasmablastic lymphoma identifies disruption of key regulatory pathways
por: Witte, Hanno M., et al.
Publicado: (2022) -
Primary refractory plasmablastic lymphoma: A precision oncology approach
por: Witte, Hanno M., et al.
Publicado: (2023) -
Clinicopathological characteristics and MYC status determine treatment outcome in plasmablastic lymphoma: a multi-center study of 76 consecutive patients
por: Witte, Hanno M., et al.
Publicado: (2020) -
Mutational landscape of high-grade B-cell lymphoma with MYC-, BCL2 and/or BCL6 rearrangements characterized by whole-exome sequencing
por: Künstner, Axel, et al.
Publicado: (2021) -
P1233: PRIMARY REFRACTORY PLASMABLASTIC LYMPHOMA: A PRECISION ONCOLOGY APPROACH
por: Witte, H., et al.
Publicado: (2022)